Literature DB >> 23712781

Diffusion-weighted MRI and its role in prostate cancer.

Tsutomu Tamada1, Teruki Sone, Yoshimasa Jo, Akira Yamamoto, Katsuyoshi Ito.   

Abstract

In the last 5 years, the multiparametric approach has been investigated as the method for the MRI of prostate cancer. In multiparametric MRI of the prostate, at least two functional MRI techniques, such as diffusion-weighted MRI (DW-MRI) and dynamic contrast-enhanced MRI, are combined with conventional MRI, such as T2 -weighted imaging. DW-MRI has the ability to qualitatively and quantitatively represent the diffusion of water molecules by the apparent diffusion coefficient, which indirectly reflects tissue cellularity. DW-MRI is characterized by a short acquisition time without the administration of contrast medium. Thus, DW-MRI has the potential to become established as a noninvasive diagnostic method for tumor detection and localization, tumor aggressiveness, local staging and local recurrence after various therapies. Accordingly, radiologists should recognize the principles of DW-MRI, the methods of image acquisition and the pitfalls of image interpretation.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Gleason score; MRI; apparent diffusion coefficient; diffusion-weighted MRI; histologic type of neoplasm; peripheral zone; prostate cancer; transition zone

Mesh:

Year:  2013        PMID: 23712781     DOI: 10.1002/nbm.2956

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  17 in total

1.  T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.

Authors:  Gabriel Nketiah; Mattijs Elschot; Eugene Kim; Jose R Teruel; Tom W Scheenen; Tone F Bathen; Kirsten M Selnæs
Journal:  Eur Radiol       Date:  2016-12-14       Impact factor: 5.315

2.  Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.

Authors:  Ayumu Kido; Tsutomu Tamada; Teruki Sone; Naoki Kanomata; Yoshiyuki Miyaji; Akira Yamamoto; Katsuyoshi Ito
Journal:  Radiol Med       Date:  2016-12-09       Impact factor: 3.469

Review 3.  Diffusion-weighted imaging in prostate cancer.

Authors:  Tsutomu Tamada; Yu Ueda; Yoshiko Ueno; Yuichi Kojima; Ayumu Kido; Akira Yamamoto
Journal:  MAGMA       Date:  2021-09-07       Impact factor: 2.533

4.  Variability in contrast and apparent diffusion coefficient of kiwifruit used as prostate MRI phantom: 1-week validation.

Authors:  Tatsuya Hayashi; Shimpei Yano; Shinya Kojima; Toshimune Ito
Journal:  Radiol Phys Technol       Date:  2022-09-05

5.  Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience.

Authors:  Ted Lee; Neil Mendhiratta; Dan Sperling; Herbert Lepor
Journal:  Rev Urol       Date:  2014

6.  Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.

Authors:  Xuefu Ji; Jiayi Zhang; Yuguo Tang; Wei Xia; Wei Shi; Dong He; Jie Bao; Xuedong Wei; Yuhua Huang; Yangchuan Liu; Jyh-Cheng Chen; Xin Gao
Journal:  Phys Eng Sci Med       Date:  2021-06-01

7.  Oncological outcomes following robotic-assisted radical prostatectomy in a multiracial Asian population.

Authors:  Low Wei Xiang Alvin; Sim Hong Gee; Huang Hong Hong; Cheng Wai Sam Christopher; Ho Sien Sun Henry; Lau Kam On Weber; Tan Puay Hoon; Lee Lui Shiong
Journal:  J Robot Surg       Date:  2015-07-07

Review 8.  Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.

Authors:  Sangjun Yoo; Jeong Kon Kim; In Gab Jeong
Journal:  Korean J Urol       Date:  2015-06-30

9.  1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer.

Authors:  Cristian Popita; Anca Raluca Popita; Adela Sitar-Taut; Bogdan Petrut; Bogdan Fetica; Ioan Coman
Journal:  Clujul Med       Date:  2017-01-15

10.  High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressiveness.

Authors:  Tsutomu Tamada; Naoki Kanomata; Teruki Sone; Yoshimasa Jo; Yoshiyuki Miyaji; Hiroki Higashi; Akira Yamamoto; Katsuyoshi Ito
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.